MDxHealth (MDXH) Cash from Financing Activities (2021 - 2026)

MDxHealth has reported Cash from Financing Activities for 5 years, with the latest figure at $16.1 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 25.0% year-over-year to $16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.5 million (up 0.71% YoY) and the FY2025 annual result came in at $3.0 million, down 93.35% from the prior year.
• Cash from Financing Activities advanced to $16.1 million in Q1 2026 per MDXH's latest filing, from $8.1 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $33.6 million in Q3 2024 and troughed at -$814000.0 in Q1 2022.
• A 4-year average of $11.0 million and a median of $9.0 million in 2025 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities plunged 75.81% in 2025, then dropped 25.0% in 2026.
• Over 4 years, Cash from Financing Activities stood at -$799000.0 in 2022, then soared by 210.64% to $884000.0 in 2024, then jumped by 818.33% to $8.1 million in 2025, then surged by 98.51% to $16.1 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $16.1 million, $8.1 million, and $9.8 million for Q1 2026, Q3 2025, and Q2 2025 respectively.